Skip to Main Content
Back to News

Insider Sale: Director at $PTCT Sells 2,381 Shares

Automated

Emma Reeve, a director at $PTCT, sold 2,381 shares of the company on 10-03-2025 for an estimated $159,217. We received data on the trade from a recent SEC filing. This was a sale of approximately 18.7% of their shares of this class of stock. Following this trade, they now own 10,332 shares of this class of $PTCT stock.

$PTCT Insider Trading Activity

PTCT Insider Trades

$PTCT insiders have traded $PTCT stock on the open market 53 times in the past 6 months. Of those trades, 0 have been purchases and 53 have been sales.

Here’s a breakdown of recent trading of $PTCT stock by insiders over the last 6 months:

  • MARK ELLIOTT BOULDING (EXEC. VP AND CLO) has made 0 purchases and 21 sales selling 77,795 shares for an estimated $4,795,507.
  • NEIL GREGORY ALMSTEAD (CHIEF TECHNICAL OPS OFFICER) has made 0 purchases and 6 sales selling 55,000 shares for an estimated $3,632,976.
  • EMMA REEVE has made 0 purchases and 13 sales selling 41,267 shares for an estimated $2,620,471.
  • ERIC PAUWELS (CHIEF BUSINESS OFFICER) has made 0 purchases and 7 sales selling 39,850 shares for an estimated $2,268,374.
  • ALLAN STEVEN JACOBSON has made 0 purchases and 2 sales selling 13,667 shares for an estimated $863,600.
  • DAVID P SOUTHWELL sold 12,000 shares for an estimated $700,080
  • MATTHEW B. KLEIN (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 2 sales selling 13,543 shares for an estimated $692,291.
  • PIERRE GRAVIER (CHIEF FINANCIAL OFFICER) sold 2,516 shares for an estimated $124,441

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$PTCT Hedge Fund Activity

We have seen 164 institutional investors add shares of $PTCT stock to their portfolio, and 116 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$PTCT Analyst Ratings

Wall Street analysts have issued reports on $PTCT in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Morgan Stanley issued a "Overweight" rating on 08/20/2025
  • Wells Fargo issued a "Overweight" rating on 08/20/2025
  • B of A Securities issued a "Buy" rating on 08/20/2025
  • RBC Capital issued a "Outperform" rating on 08/08/2025
  • Cantor Fitzgerald issued a "Overweight" rating on 07/29/2025
  • UBS issued a "Buy" rating on 07/29/2025
  • Truist Securities issued a "Buy" rating on 07/29/2025

To track analyst ratings and price targets for $PTCT, check out Quiver Quantitative's $PTCT forecast page.

$PTCT Price Targets

Multiple analysts have issued price targets for $PTCT recently. We have seen 11 analysts offer price targets for $PTCT in the last 6 months, with a median target of $71.0.

Here are some recent targets:

  • Kristen Kluska from Cantor Fitzgerald set a target price of $118.0 on 09/03/2025
  • Tiago Fauth from Wells Fargo set a target price of $73.0 on 08/20/2025
  • Tazeen Ahmad from B of A Securities set a target price of $76.0 on 08/20/2025
  • Jeffrey Hung from Morgan Stanley set a target price of $71.0 on 08/20/2025
  • Brian Abrahams from RBC Capital set a target price of $63.0 on 08/08/2025
  • Joon Lee from Truist Securities set a target price of $86.0 on 07/29/2025
  • Colin Bristow from UBS set a target price of $80.0 on 07/29/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles